2024 International Congress » Drug-Induced Movement Disorders

A Rare Manifestation of Oculogyric Crisis in Schizophrenia Patients with Risperidone: Case Series

D. Siregar, D. Tunjungsari, A. Tiksnadi, E. Hanafi (Jakarta Pusat, Indonesia)

Acute dystonic dyskinesias in a patient used fluvoxamine. Case report

A. Katok, D. Khasanova, G. Ilina (Kazan, Russian Federation)

Bistriatal hypermetabolism on 18-FDG PET-CT in tardive dyskinesia

C. Héraud, C. Alecu, C. Giordana (NICE, France)

Case Report: Carbamazepine-Induced Dystonia, Tremor and Negative Myoclonus

D. Ouhabi, H. Naciri Darai, H. Tibar, W. Regragui (Rabat, Morocco)

Central Tremor after CAR-T Cell Therapy: A Case with Neurophysiologic Characterization

O. Halhouli, Z. Ni, H. Cho, M. Hallett (Bethesda, USA)

Comorbid Tardive Dyskinesia (TD) and Restless Leg Syndrome (RLS)

V. Chang, T. Stiep (San Francisco, USA)

Complete Resolution of Tardive Dystonia After Bilateral Globus Pallidus Interna Deep Brain Stimulation

L. Okar, P. Murin, C. Pratap (St.Louis, USA)

Craniofacial Myoclonus: A Disabling Complication of Amantadine Therapy

S. Bhushan, Mph, S. Brillman, Md (Palo Alto, USA)

Drug-Induced Parkinsonism and Tardive Dyskinesia in Rats Chronically Treated with Haloperidol

H. Hikichi, H. Nishijima, F. Mori, I. Kinoshita, C. Murakami, M. Tomiyama (Hirosaki, Japan)

Drug-induced tremors: A scoping review to assess knowledge gaps, controversies, and future directions

S. Desai, D. Desai (Anand, India)

GPR30 agonists attenuate haloperidol-induced neurotoxicity in SH-SY5Y cells and adult zebrafish.

SHU. Upadhayay, PKB. Kumar (Baathinda, India)

Ibudilast, a Phosphodiesterase Inhibitor, Alleviates Huntington’s Disease Pathology through Neuroinflammation Modulation and Signaling Pathway Regulation in a Rat Model

S. -, V. Parcha (Dehardun, India)

Neuroprotective Efficacy of Ethanolic Extract from Amorphophallus Paeoniifolius Tuber Against Haloperidol-Induced Parkinson’s Disease Model

R. Kumar, S. Choudhary (Handia,, India)

Oro-facial Dyskinesia and akathisia following Treatment by Olanzapine

S. Saaf, S. Lhassani, Z. El Yacoubi, Y. Mimouni, M. El Azhari, L. Kazzoul, J. Aasfara, H. Ouhabi, A. Hazim (Casablanca, Morocco)

Prevalence of Movement Disorders in Epilepsy Patients Taking Antiepileptics Drugs in a Tertiary Care Teaching Hospital in Nepal.

N. Guragain, P. Gyawanli, A. Mudvari, P. Prasad, R. Ghimire, B. Gajurel, R. Ojha (Kathmandu, Nepal)

Quantitative EEG Analysis for Comparing Drug-Induced Parkinsonism and Parkinson’s Disease

S. Seo, S. Kim, SP. Kim, J. Kim, D. Chung, SY. Kang (Ulsan, Republic of Korea)

Rare Clinical Manifestation of Tardive Dyskinesia In Schizophrenic Patient on Quetiapine and Sertraline: A Case Report

H. Oktaviani, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)

Response inhibition in patients with Lithium induced Tremor

S. Banerjee, S. Choudhury, S. Majumdar, A. Bayen, P. Jakati, M. Baker, S. Baker, H. Kumar (KOLKATA, India)

Reversing the irreversible: The application of Deep Brain Stimulation in The Syndrome of Irreversible Lithium Effectuated Neurotoxicity.

L. Okar, P. Murin, A. Prabhune, C. Pratap (St.Louis, USA)

Tardive Dystonia Following Risperidone Treatment : A Case Report and Therapeutic Approach

M. Hildaria, D. Tunjungsari, A. Tiksnadi (Central Jakarta, Indonesia)

The Neuroprotective Effects of Rolipram, a Selective Phosphodiesterase IV Inhibitor, on Parkinson’s Disease in Rat Models: A Pharmacological Exploration in both In vivo and In vitro Settings

R. Kumar, A. Kanojia (Darbhanga, India)